ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,513,000 | -15.2% | 1,036,525 | -17.6% | 0.00% | 0.0% |
| Q4 2016 | $1,785,000 | -15.1% | 1,257,325 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $2,102,000 | -2.2% | 1,257,325 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,150,000 | -17.9% | 1,257,325 | -5.4% | 0.00% | 0.0% |
| Q1 2016 | $2,618,000 | +3.7% | 1,329,146 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $2,525,000 | -0.6% | 1,329,146 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,539,000 | -64.8% | 1,329,146 | -14.4% | 0.00% | -75.0% |
| Q2 2015 | $7,205,000 | -9.0% | 1,552,860 | -14.3% | 0.00% | 0.0% |
| Q1 2015 | $7,921,000 | +18.2% | 1,812,577 | -6.1% | 0.00% | +33.3% |
| Q4 2014 | $6,700,000 | -17.2% | 1,930,782 | 0.0% | 0.00% | -25.0% |
| Q3 2014 | $8,090,000 | -64.3% | 1,930,782 | -50.0% | 0.00% | -33.3% |
| Q2 2014 | $22,630,000 | +114.0% | 3,861,564 | +130.1% | 0.01% | 0.0% |
| Q1 2014 | $10,573,000 | +7.7% | 1,678,128 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $9,817,000 | +11.0% | 1,678,128 | 0.0% | 0.01% | +20.0% |
| Q3 2013 | $8,844,000 | +2.5% | 1,678,128 | +49.7% | 0.01% | 0.0% |
| Q2 2013 | $8,632,000 | +380.4% | 1,121,023 | +412.2% | 0.01% | +400.0% |
| Q1 2013 | $1,797,000 | – | 218,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |